MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
56 hedge funds and large institutions have $23.8M invested in Merrimack Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 14 closing their positions.
Holders
56
Holders Change
-7
Holders Change %
-11.11%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
13
Reduced
22
Closed
14
Calls
–
Puts
$23K
Net Calls
-$23K
Net Calls Change
+$15K
Top Buyers
1 |
2L
1
22NW LP
Seattle,
Washington
|
$2.89M |
2 |
SC
2
Sepio Capital
Salt Lake City,
Utah
|
$1.59M |
3 |
NM
3
Newtyn Management
New York
|
$3.43M |
4 |
WSL
4
Western Standard LLC
Los Angeles,
California
|
$580K |
5 |
JGC
5
J. Goldman & Co
New York
|
$587K |